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INTRODUCTION 
Ayurveda is a traditional system of medicine using a wide  
range of modalities to create health and well being. The 
primary aim of Ayurveda health care is to restore the 
physical mental and emotional balance in patients, thereby 
improving health, preventing disease and also treating any 
current illness. The number of patients seeking alternate 
and herbal therapy is growing exponentially. Herbal 
medicines are now in great demand in the developing 
world for primary healthcare not because they are 
inexpensive but also for better cultural acceptability, better 
compatibility with the human body and minimal side 
effects. Herbal medicine is still the mainstay of about 75–
80% of the world population, mainly in the developing 
countries for primary healthcare. However among the 
estimated 250,000-400,000 plant species, only 6% have 
been studied for biological activity, and about 15% have 
been investigated phytochemically 
1, 2.
 Therefore it seems 
necessary to evaluate the herbs properly. 
GENERAL INFORMATION 
Berberis aristata DC. (Fam. Berberidaceae) is one of the 
herbs mentioned in all ancient scriptures of Ayurveda, 
Charaka and Susruta have mentioned it’s different 
properties along with various used for the treatment of 
numerous illnesses. As it resembles in its properties to 
those of haridra, both the herbs have been mentioned 
together as haridra dvaya, meaning two haridras viz. 
haridra and daruharidra. Charaka has categorized  
daruharidra as stanyasodhana – lactode purant, lekhana – a 
reducing herb, arsoghna – anti – haemorrhoidal, 
kandughna – anti – haemorrhoidal, kandughna – anti – 
pruritic  and as svedala – promotes sweating, rasayana-  
 
rejuvenative. Susruta have me ntioned it as ropana – a 
wound healer. 
English names: Indian barberry, tree turmeric . Indian 
names: darhaldi (Bengal), kashmoi (Garhwal), rasont, 
kashmal (Himachal Pradesh), chitra, dar-hald, rasaut, 
kashmal (Hindi), maradarisina, maramanjal, (Kerala), 
daruhald (Maharashtra), chitra, chutro (Nepal),chitra, 
kasmal. simlu, sumlu (Punjab) mullukala, usikkala (Tamil 
Nadu), daruharidra, darvi, kata, pitadaru, suvarnavarna 
(Sanskrit ). 
There are 12 – 13 varieties like Berberis asiatica, Berberis 
lycium, Berberis vulgaris, Berberis nepalensis etc. The 
root and wood are rich in a yellow alkalo id berberine, a  
bitter substance, which dissolves in acids and forms salts 
of the alkaloid. The root contains two more alkalo ids. A 
protoberberine alkalo id karachine is isolated and 
characterized, and taxalamine is also isolated. A 
protoberberine alkaloid – karachine – isolated and 
characterized and also taxilamine isolated. The plant is 
native of the whole range of Himalaya mountains at an 
elevation 2000 to 3500 metres. It also occurs in Nilagiri 
range in Southern India . The shrub grows upto 1.5 – 2.0 
metres in height, with a thick woody root covered with a 
thin brittle bark. The leaves are cylindrical, straight, 
tapering, very sharp, hard, smooth spines. The flowers 
yellow, numerous, stalked, arranged in drooping racemes. 
The fruit is a small berry, ovoid and smooth. It flowers in  
April and May. 
Berberis aristata DC. is an erect spinous shrub, often 
found in small patches on the bill slopes. It is one of very 
important medicinal plants. Almost every part of this plant 
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has some medicinal value. Its roots, stem, bark and fruits 
are used in many ayurvedic preparations. This shrub is 
found growing wild in the sub-Himalayan tract at altitude 
ranging from 850-2,500 metres. It  also grows in  the 
Nilgiris and in Ceylon. 
 PHARMACOGNOSTICAL STUDIES  
It is an erect spiny shrub, ranging between 2 and 3 metres 
in height wood, hard and yellow;  bark, yellow to brown 
from outside and deep yellow from inside, removable in  
longitudinal strips by hand; spines (which, in fact, are 
modified leaves), three-branched and 1.5 cm long. Leaves, 
in tufts of 5 to 8, phyllotaxy verticillate, lanceolate, simple 
spiny, toothed, leathery, sessile, acuminate, with reticulate 
pinnate venation, 4.9 cm. long, 1.8 cm. b road, deep green 
on the dorsal surface and light green on the ventral 
surface.
3
 
Flowers, stalked, yellow, complete, hermaphrodite, cyclic, 
actinomorphic, perigynous, the average diameter of a fu lly  
opened flower being 12.5 mm; in florescence, a simple to 
corymbose raceme, with 11 to 16 flowers per cluster; 
calyx, yellow, polysepalous, with 6 sepals (3 small, 3 
large), yellow, act inomorphic caducous, 4 to 5 mm long; 
corolla, polypetalous, with 6 petals, yellow, actinomorphic, 
4 to 5 mm long; androecium, polyandrous, with 6 stamens, 
adnate, 5 to 6 mm long; gynoecium, one, 4 to 5 mm long, 
with a short style and a broad stigma.  Fruits, globose to 
ovoid, usually covered with bloom as in plums, 7 mm 
long, 4 mm in diameter, weighing 227 mg, 237 microlitres 
in volume; fruit colour, aconite violet 937; colour of pulp 
and juice, plum purple 934/3. Seeds, 2 to 5, varying in  
colour from yellow to pink, each weighing 25 mg and 
being 29 microlitres in vo lume. Flowering in Berberis 
aristata starts from the first fortnight of March and 
remains in progress up to the end of April. The peak 
flowering season under Solan conditions was recorded to 
be from 8-25 April. The fruits start ripening from the 
second week of May and continue to do so throughout 
June. They can be retained on the shrub after ripening for 
quite a long period, but they fall off soon after the onset of 
rains. The fruit ing season, therefore, ends abruptly with the 
commencement of the rainy season. An average-sized bush 
of Berberis aristata was found to yield 657 g of fru its in 
about 4 pickings. 
PHYTOCHEMISTRY 
The plant contains barberine, oxyberberine, berbamine, 
aromoline, karachine, palmat ine, oxyacanthine and 
taxilamine. 
4
 Berberis  aristata  contains  protoberberine  
and  bis  isoquinoline  type  of  alkaloid.  Root  of  plant  
Berberis  aristata contains  alkaloid  which  are  
berbamine,  Berberine, oxycanthine,  epiberberine,  
palmatine,  dehydrocaroline, jatrorhizine and 
 columbamine,
5,6
 karachine,
7 
dihyrokarachine, 
taximaline,
8 
oxyberberine,  aromoline.
9  
Four 
 alkaloids, pakistanine,  1-O methyl 
pakistanine,  pseudopalmat ine  ch loride    and 
pseudoberberine  chloride  were  also  isolated    from 
Berberis  aristata.
10,11
    A  secobisbenzlisoquinoline  or 
simple  isoquinoline  alkalo id  was  isolated  from Berberis 
aristata.
12 
The  major  alkaloid  found  in   Berberis  
aristata  is Berberine  having  yield  of  2.23%  followed   
by palamatine.
13 
Variation  of  Berberine  content  in  root  
and  stem  of  Berrberis aristata with alt itude was 
determined. It  was  found that plants  growing  at  lower  
altitude  have  more  Berberine content. Berberine content 
in plant is also influenced by potassium  and  moisture  
content  of  soil.
14 
HPTLC fingerprint ing  of  Berberine  in   
Berberis  aristata  was  done  to quantify  the  amount  of  
Berberine.  Total  alkalo idal content of Berberis aristata 
was also done.
1 
Berberine
 
 
 
Berbamine 
 
Oxyberberine  
 
 
Aromoline  
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Oxyacanthine  
 
TRADITIONAL MEDICINAL US ES  
Berberis aristata has played a prominent ro le in herbal 
healing for more than 2,500 years. The ancient Egyptians 
used it to prevent plagues. India’s Ayurvedic healers used 
it foe dysentery. During the early midd le ages, European 
herbalists used it to treat liver and gallbladder ailments. 
Russian healers used it for inflammations, high blood 
pressure, and for abnormal uterine bleeding. American  
Indians recognize barberry as similar to Oregon grape. 
Tincture made from Berberis aristata is used as a bitter 
tonic, stomachic, cholagogue, antiperiodic and alterative, 
in cases of remittent as well as intermittent fevers and also 
in debility consequent there from and is very effective in  
periodic neuralgia and menorrhagia.
12 
As an antiperiodic 
on frequently repeated admin istration, it doses not produce 
is the case with cinchona and quinine and it may be used 
during the attack of fever. Rasaut a preparation of Berberis 
aristata mixed with honey is useful in the treatment of 
aphthous sores abrasions and ulcerations of the skin. The 
plant is an emmenagogue and is useful in the treatment of 
jaundice, enlargement of spleen, etc. the drug is also 
regarded as laxative, diaphoretic, antipyretic and 
antiseptic. Berberis aristata root bark decoction is 
externally used as a wash in painful eye affections, ulcers 
and hemorrhoids. In the Unani system of medicine, it is 
used for the treatment of leprosy. Decoction of roots of 
Berberis aristata is used for skin troubles and in blood 
purification.
 13-16
 
PHARMACOLOGY 
Berberis aristata DC. are given as a cooling laxative to 
children. The stem is said to be diaphoretic and laxative 
and useful in rheumatis m. The dried extract of the roots is 
used as an application in ophthalmia. It is also an excellent 
medication in the case of sun-blindness. The bark of its 
root is a valuable medicine in intermittent and remittent 
fevers. The root is one of the few really good medicines in 
India. In its efficacy, it is almost equal to quinine and 
Warburg's tincture. It does not produce any bad effects on 
the stomach, the bowels, the brain and the organs of 
hearing.
16-17
 
A very valuable preparation called rasaut is prepared from 
this plant. For preparing rasaut, the bark of the root and of 
the lower part of the stem is boiled in water, strained and 
evaporated till a semi-solid mass (rasaut) is obtained. 
Rasaut is fairly soluble in water. It is mixed with butter 
and alum, or with opium and lime-juice and is applied  
externally to the eyelids to cure ophthalmia and other eye 
diseases.
18 
It is also reported to be a mild laxat ive, a tonic 
and is useful in curing ulcers and fevers .
 18
 
Dastur in 1962 has reported that the chief constituent of 
Berberis aristata is barberine, which is a bitter alkaloid. 
According to him, rasaut is used as a purgative for children  
and as a blood-purifier, a tonic and a febrifuge. It is also 
given in diarrhoea, jaundice and skin diseases. A watery 
solution of this preparation is also used for washing piles, 
oriental sores and glandular swellings.
 18
 
ANTI – MICROBIAL  
The antimicrobial activity of hydroalcoholic extracts of. 
Berberis aristata, were tested against eleven bacterial, 
Micrococcus luteus, Bacillus subtilis, Berberis cereus,  
Enterobactor aerogenus, Escherichia coli, Klebsiella 
pneumoniae,  Proteus mirabilis,  Pseudomonas 
aeruginosa,  Staphylococcus aureus, Salmonella 
typhimurium, Streptococcus pneumoniae,  and eight fungal 
strains. Aspergillus nidulans, Candida albicans,  
Aspergillus terreus,  Trichophyton rubrum,   Aspergillus 
spinulosus, Cryptococcus albidus, Aspergillus flavus, 
Aspergillus niger.  Berberis aristata root extract gave low 
MICs values against Bacillus cereus, Escherichia coli, 
Staphylococcus aureus and Aspergillus flavus while stem 
extract against Berberis cereus and Streptococcus 
pneumoniae. The hydroalcoholic extracts of root of the 
Berberis aristata were effective against most of the tested 
bacteria. Like Berberis lycium,   Berberis aristata and 
Berberis asiatica and also showed significant antifungal 
activity against Aspergillus terreus and Aspergillus flavus. 
Berberis aristata root and Berberis lycium  stem extracts 
gave very low MIC values with the concentration of 0.3 
µg/ml. The major alkalo id berberine may be responsible 
for antimicrobial act ivity.
 19
 
ANTI-DEPRESSANT 
Berberine, an alkalo id isolated from Berberis aristata 
Linn. has been used in the Indian system of medicines as  a 
stomachic, bitter tonic, antiamoebic and also in the 
treatment of oriental sores. Evidences have demonstrated 
that berberine possesses central nervous system activit ies, 
particularly the ability to inhibit monoamine oxidase-A, an 
enzyme involved in the degradation of norepinephrine and 
serotonin (5-HT). W ith this background, the present study 
was carried out to elucidate the antidepressant-like effect  
of berberine chloride in different behavioural paradigms of 
despair. Berberine (5, 10, 20 mg/kg, i.p.) inhibited the 
immobility period in mice in  both forced swim and tail-
suspension test, however, the effect was not 
dosedependent. Berberine (5 and 10 mg/kg, i.p.) also 
reversed the reserpine-induced behavioral despair.
 20
 
Berberine (5 mg/kg, i.p.) enhanced the anti-immobility 
effect of subeffective doses of various typical but not 
atypical antidepressant drugs in forced swim test. 
Berberine (5 mg/kg, i.p.) fo llowing its acute administration 
in mice resulted in increased levels of norepinephrine 
(31%), serotonin (47%) and dopamine (31%) in the whole 
brain. Chronic admin istration of berberine (5 mg/kg, i.p.) 
for 15 days signi.cantly increased the levels of 
norepinephrine (29%), serotonin (19%) as well as 
dopamine (52%) but at higher dose (10 mg/kg, i.p.), there  
was no change in the norepinephrine (12%) levels but a 
significant increase in the serotonin (53%) and dopamine 
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(31%) levels was found. The antidepressant-like effect of 
berberine (5 mg/kg, i.p.) in forced swim test was prevented 
by pretreatment with L-argin ine (750 mg/kg, i.p.) or 
sildena.l (5 mg/kg, i.p.). On the contrary, pretreatment of 
mice with 7-nit roindazole (7-NI) (25 mg/kg, i.p.) or 
methylene blue (10 mg/kg, i.p.) potentiated the effect of 
berberine (2 mg/kg, i.p.) in the forced swim test. 
Pretreatment of mice with (+)- pentazocine (2.5 mg/kg, 
i.p.), a h igh-af.n ity sigma1 receptor agonist, produced 
synergism with subeffective dose of berberine (2 mg/kg, 
i.p.). Pretreatment with various sigma receptor antagonists 
viz. progesterone (10 mg/kg, s.c.), rimcazole (5 mg/kg, 
i.p.) and N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-
(dimethylamino) ethylamine (BD1047; 1 mg/kg, i.p.) 
reversed the anti-immobility effects of berberine (5 mg/kg, 
i.p.). Berberine at lower dose did not affect the locomotor 
activity and barbiturate-induced sleep time. It produced 
mild hypothermic action in rats and displayed analgesic 
effect in mice. Taken together, theses  finndings 
demonstrate that berberine exerted antidepressant-like 
effect in various behavioural paradigms of despair possibly 
by modulating brain biogenic amines (norepinephrine, 
serotonin and dopamine). Further, nitric oxide pathway 
and/or sigma receptors  are involved in mediating its 
antidepressant-like activ ity in mouse forced swim test.
 20 
DIABETES  MELLITUS  
An uncontrolled clin ical trial investigated the effect of 
berberine on 60 patients with type 11 diabetes mellitus. 
The patients varied in severity of this disorder. Oral doses 
(0.3-0.5 g three times a day) were prescribed for 1-3 
months, together with a therapeutic diet prescribed for 1 
month. Major symptoms of d iabetes disappeared patients 
strength improved, blood pressure became normal and 
blood lipids decreased. Fasting glycaemic levels in 60% of 
patients ere controlled. Further testing in animal models 
indicated that treatment with berberine led to healthier 
pancreatic tissue compared to controls. It is suggested that 
the mechanism of action of berberine may be associated 
with promoting regeneration and functional recovery of β-
cells.
 21,29
 
HEPATOPROTECTIVE  
In earlier studies, we demonstrated that this folkmedical 
use had scientifically justified basis, as the crude extract of 
Berberis aristata leaves and fruits showed 
hepatoprotection possibly through inhibitory action on 
hepatic drug metabolizing enzymes 
21-22
. In this 
investigation we provide evidence that berberine is  to be 
considered the active principle of these extracts. berberine, 
a known compound from Berbris aristata  plant, was 
studied for its possible anti-hepatotoxicact ion in rats. 
Pretreatment of animals with berberine 4 mg/kg; orally  
twice daily for 2 days prevented the acetaminophen or 
CCl4 induced rise in serum levels of alkaline phosphatase 
ALP and aminotransaminases AST and ALT , suggestive 
of hepatoprotection. Post-treatment with three successive 
oral doses of berberine 4 mg/kg every 6 h reduced the 
hepatic damage induced by acetaminophen, while CCl4 -
induced hepatotoxicity was not modified, suggesting a 
selective curative effect against acetaminophen. 
Pretreatment of animals with a single oral dose of 
berberine 4 mg/kg induced prolongation of the 
pentobarbital 60 mg/ kg, i.p. -induced sleeping time as well 
as increased strychnine 0.3 mg/kg; i.p. -induced toxicity, 
suggestive of inhibitory effect on microsomal drug 
metabolizing enzymes, cytochrome P450s CYPs . 
25-27
 
INOTROPIC ACTIVITY 
Berberis aristata is an edible plant employed in South 
Asian traditional medicine; in particular, its fruit is used as 
a tonic remedy for liver and heart. In isolated cardiac 
tissues, Berberis aristata fruit extract exh ibits a positive 
inotropic action. Activity-directed fractionation using 
organic solvents revealed that the cardiotonic activity is 
concentrated in the n-butanolic fraction (BF). The cardiac 
action of BF was investigated in spontaneously beating 
right atria and in electrically driven right ventricular strips 
and left atria obtained from reserpin ized guinea pigs. The 
results show that this fraction produces a dose-dependent 
positive inotropic action with little effect on heart rate. To 
study its possible mode of action, guinea pig atria were 
pretreated with propranolol, a b-adrenoceptor blocking 
agent. This treatment abolished the cardiotonic effect of 
isoprenaline, whereas the cardiotonic effect of BF 
remained unaltered, suggesting that this effect does not 
involve stimulat ion of b-adrenoceptors. On the other hand, 
application of carbachol reverses only part of the BF-
induced increase in ventricular force of contraction, 
indicating that besides a cyclic AMP (cAMP)-dependent 
mechanis m, a cAMP-independent mechanism underlies 
the inotropic action of BF. This is in line with the 
observation that the dynamics of isometric twitch 
contractions are not significantly altered by BF. 
Investigations in skinned myocardial preparations showed 
that BF modulates the calcium-dependent interaction of 
actin and myosin, apparently by reducing the cooperativity 
of the calcium-dependent binding of myosin to actin, i.e., 
there is enhanced calcium activation at low to 
physiological intracellular calcium, and reduced calcium 
activation at high intracellular calcium concentrations as 
present, for example, in ischemic  calcium overload. These 
data indicate that the edible plant, Berberis aristata, 
contains active princip le(s) that cause(s) a selective 
inotropic effect, involving—in the form of the modulatory 
effect on actin myosin cooperativity—a novel mechanism 
of action. Further phytochemical and pharmacological 
studies may lead to isolation and structural identificat ion 
of an attractive, new cardiotonic agent from Berberis 
aristata fruit.
 16-20
 
IMMUNOMODULATORY ACTIVITY 
The activity of a crude extract formulation was evaluated 
in experimental immunomodulation studies. The 
formulat ion comprises the following five p lants - 
Boerhavia diffusa, Tinospora cordifolia, Berberis aristata, 
Terminalia chebula and Zingiber officinale. In 
immunomodulation studies humoral immunity was 
enhanced as evidenced by the haemagglutination titre. The 
T-cell counts remained unaffected in the animals treated 
with the formulation but cell-mediated immune response 
was stimulated as observed in the leukocyte migrat ion 
inhibit ion (LMI) tests.
17 
INFLUENCE ON T-CELL MEDIATED IMMUNITY 
The protoberberine alkalo id berberin is isolated as a main  
alkaloid from the roots and bark of Berberis vulgaris. 
Berberine strongly inhibited in vit ro the proliferative 
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response of mouse spleen cells to Tdependent mitogens 
concanavalin A (con A) and phytochemagglutinin (PHA). 
Spleen cells obtained from berberine-t reated mice (10 
mg/kg/3) days) expressed enhanced proliferative response 
to both mitogens. Berberine was applied to mice at  
different intervals before or after the induction of adjuvant 
arhrit is (AIA) and Candida albicans (C. albicans) 
infection. The application of the alkalo id to new born mice 
(5 days after birth at a dose of 5 mg/kg/3 days) did not 
change the course of AIA and C. albicans infection. Its  
application at three 10 day intervals (5 mg/kg), starting 
from the 5 day after birth increased the joint inflammat ion 
in AIA. The host resistance to C. albicans infection was 
not affected, while the delayed type hypersensitivity 
(DTH)-reaction against the pathogen was enhanced. The 
alkaloid inhib ited the development of AIA when applied  
after its onset (10 mg/kg from day +3 to +12 day). 
Berberine treatment during the ongoing infection did not 
influence its outcome (from +2 to +10 day). Berbamine, an  
ingredient of Berberis, which itself is widely utilized in  
Chinese folk medicine has been used as a source of 
leukogenics, anti-arrhythmics and anti-hypertensives. In 
recent years the immunosuppressive effects of berbamine 
has been demonstrated. In order to further investigate the 
value of berbamine as an immunosuppressive agent, the 
delayed type hypersensitivity reaction (DTH) response 
with sheep red blood cells (SRBC), the mixed lymphocyte 
reaction (MLR) and a skin model of allograft rejection on 
mice were studied. Berbamine showed suppressive effects 
on DTH and MLR and significantly prolonged allograft  
survival compared  with untreated transplanted mice. The 
results indicate that berbamine may be a potential agent in 
clin ical transplantation.
 16-17.
 
HEPATIC AMOEBIAS IS 
The activity of a crude extract formulation was evaluated 
in experimental amoebic liver abscess in golden hamsters . 
The formulation comprises the following five plants - 
Boerhavia diffusa, Tinospora cordifolia, Berberis aristata, 
Terminalia chebula and Zingiber officinale. The 
formulat ion had a maximum cure rate of 73% at a dose of 
800 mg/kg/day in hepatic amoebiasis reducing the average 
degree of infection (ADI) to 1.3 as compared to 4.2 for 
sham-treated controls.
 18
 
ANTI-CARCINOGENIC ACTIVITY 
Berberin, an alkalo id isolated from the plant Berberis 
aristata, has been found to inhibit significantly the 
carcinogenesis induced by 20-methylcholanthrene (200 
microg/0.1 mL/mouse) or N-nit rosodiethylamine (NDEA; 
0.02% NDEA in distilled water, 2.5 mL/animal by gavage, 
five days a week for 20 weeks) in a dosedependent manner 
in small animals. Administration of berberine (0.5, 2.5 or 
5.0 mg kg(-1) could reduce significantly the incidence of 
tumor in animals after an injection of 20-
methylcholanthrene and increased their life span compared 
with the control. When berberine (10, 25 or 50 mg kg(-1)) 
was admin istered simultaneously with NDEA, the markers 
of liver in jury (liver weight, gamma -glutamyl 
transpeptidase activity and glutathione S-transferase level) 
were reduced significantly compared with animals treated 
with NDEA only, which resulted in all the values being 
elevated. A similar decrease was noted in the serum levels 
of lipid peroxide, bilirubin and glutamate pyruvate 
transaminase. Morphology of liver tissue and levels of 
marker enzymes indicated that berberine offered protection 
against chemicalcarcinogenesis. Methanolic extract of 
stems of Berberis aristata is also showing promising 
results against breast and colon cancer cell lines. Hence, it  
is effective against breast and colon cancers. 
 19,23,24.
 
MIS CELLANEOUS  
Berberis aristata, an edible plant (family Berberidaceae, 
local name Zarshik ), has been used since ancient times in 
South Asian traditional medicine as an herbal tonic for 
liver and heart. In our earlier studies we demon- that the 
folkloric use in hepatic damage has a scientifically  
justified basis, as the crude ext ract of Berberis aristata 
fruits and leaves showed hepatoprotection in an animal 
model of hepatotoxicity.
 20-29
 
CONCLUS ION 
Berberis aristata is commonly found throughout India. 
Studies have revealed its use in antimicrobial, 
hepatoprotective, immunomodulatory, and anti-depressant. 
However not much information is there to prove this plant 
for anti-neoplastic, anti-fert ility, anti-leprotic etc. therefore 
further studies may be carried out to prove the potential of 
this plant. The plant is becoming the endangered species 
now so more work can be done on agricultural and 
climatic conditions to grow this plant. The translational 
potential and clues to possible novel bioactivities and 
novel targets yet to be discovered with this amazing plant 
species can be gauged from the plethora of patents  being 
awarded. 
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